3,4-Methylenedioxymethamphetamine (MDMA; "ecstasy") is a potentially neurotoxic recreational drug of abuse. Though the mechanisms involved are still not completely understood, formation of reactive metabolites and mitochondrial dysfunction contribute to MDMA-related neurotoxicity. Neuronal mitochondrial trafficking, and their targeting to synapses, is essential for proper neuronal function and survival, rendering neurons particularly vulnerable to mitochondrial dysfunction. Indeed, MDMAassociated disruption of Ca 2+ homeostasis and ATP depletion have been described in neurons, thus suggesting possible MDMA interference on mitochondrial dynamics. In this study, we performed real-time functional experiments of mitochondrial trafficking to explore the role of in situ mitochondrial dysfunction in MDMA's neurotoxic actions. We show that the mixture of MDMA and six of its major in vivo metabolites, each compound at 10M, impaired mitochondrial trafficking and increased the fragmentation of axonal mitochondria in cultured hippocampal neurons. Furthermore, the overexpression of mitofusin 2 (Mfn2) or dynamin-related protein 1 (Drp1) K38A constructs almost completely rescued the trafficking deficits caused by this mixture. Finally, in hippocampal neurons overexpressing a Mfn2 mutant, Mfn2 R94Q, with impaired fusion and transport properties, it was confirmed that a dysregulation of mitochondrial fission/fusion events greatly contributed to the reported trafficking phenotype. In conclusion, our study demonstrated, for the first time, that the mixture of MDMA and its metabolites, at concentrations relevant to the in vivo scenario, impaired mitochondrial trafficking and increased mitochondrial fragmentation in hippocampal neurons, thus providing a new insight in the context of "ecstasy"-induced neuronal injury.
3,4-Methylenedioxymethamphetamine (MDMA; "ecstasy") is a worldwide major drug of abuse with well-documented neurotoxic properties, both in humans (Roberts et al., 2009; Tai et al., 2011) and in laboratory animals (Bai et al., 2001; Granado et al., 2011) . Though the molecular and cellular mechanisms underlying MDMA's neurotoxicity remain poorly understood, recent studies have attributed a possible role to mitochondrialdependent pathways (Alves et al., 2007 (Alves et al., , 2009a Puerta et al., 2010; Quinton and Yamamoto, 2006) . Hepatic formation of reactive metabolites, followed by their uptake into the brain (Erives et al., 2008; Jones et al., 2005) , has also been postulated to contribute to MDMA-related neurotoxicity (Barbosa et al., 2012 (Barbosa et al., , 2014a Capela et al., 2006 Capela et al., , 2007 Capela et al., , 2009 , though their role in MDMA-induced mitochondrial dysfunction is unknown. Furthermore, mitochondrial effects of the mixture of MDMA and its major metabolites, as it occurs in vivo, remain uncharacterized. In fact, one of the most important limitations of in vitro neuronal models is the lack of cytochrome P450 (CYP450)-mediated drug's metabolism (Ferguson and Tyndale, 2011) , which implies that the coexposure to parent compound and its metabolites is rarely tested (Barbosa et al., 2014b) .
The hepatic metabolism of MDMA is mainly regulated by CYP450 enzymes, originating 3,4-408 BARBOSA ET AL. methylenedioxyamphetamine (MDA) by N-demethylation. Both MDMA and MDA are then O-demethylenated to the catecholic compounds N-methyl-␣-methyldopamine (N-Me-␣-MeDA) and ␣-methyldopamine (␣-MeDA), respectively, which can undergo oxidation to the correspondent redox-active ortho-quinones (Pizarro et al., 2004) . These ortho-quinones may be conjugated with reduced glutathione (GSH), originating glutathionyl adducts (Erives et al., 2008) . The systemic formation of 5-(glutathion-S-yl)-Nmethyl-␣-methyldopamine [5-(GSH)-N-Me-␣-MeDA] and 5-(glutathion-S-yl)-␣-methyldopamine [5-(GSH)-␣-MeDA] is followed by their uptake into the brain (Erives et al., 2008; Jones et al., 2005) , where they may undergo further metabolism to N-acetyl-cysteine (NAC) conjugates, which are slowly eliminated, and, consequently, persistent in the brain (Jones et al., 2005) . Supporting a role for metabolism in MDMA-induced neurotoxicity, Gollamudi et al. (1989) showed an attenuation of MDMA-mediated 5-HT deficits after inhibition of CYP450-mediated MDMA's metabolism. Therefore, it is expected that MDMA's neurotoxic actions may result from a combined effect between parent compound and its metabolites, as they coexist in the brain (Chu et al., 1996; Erives et al., 2008; Jones et al., 2005; Mueller et al., 2009 ). However, the mechanistic studies performed in vitro frequently investigate each compound alone, which excludes the contribution of the mixture of MDMA and its metabolites encountered in vivo. Notably, we previously demonstrated that the mixture of MDMA and its metabolites, at in vivo relevant concentrations (Chu et al., 1996; Erives et al., 2008; Jones et al., 2005) , triggered cellular adaptations and toxicity in human SH-SY5Y differentiated cells, which provided a new breakthrough in the context of MDMA-induced neurotoxicity (Barbosa et al., 2014b) .
Mitochondria are highly dynamic organelles that, by undergoing fission and fusion events, can display significant variability in their size and shape. In neurons, these opposing processes appear to play a key role in regulating mitochondrial distribution along axons and dendrites, rendering neuronal cells critically dependent on mitochondrial dynamics (Sheng and Cai, 2012) . Mitochondrial fission is mediated by an evolutionarily conserved soluble cytosolic dynamin-related guanosine 5 -triphosphatase (GTPase) protein, the dynamin-related protein 1 (Drp1), whose interaction with mitochondria is regulated by posttranslational modifications (Itoh et al., 2013) and Ca 2+ (Cereghetti et al., 2008) . Mitochondrial fusion is mediated by the dynamin-related GTPase proteins, mitofusin 1 (Mfn1), mitofusin 2 (Mfn2), and optic dominant atrophy 1 (Opa1) (Itoh et al., 2013) . Whereas Mfn1 and Mfn2 are involved in the outer mitochondrial membrane fusion, Opa1 mediates fusion of the inner membrane (Song et al., 2009) . A disruption of this dynamic equilibrium between mitochondrial fusion and fission may herald neuronal injury or death and contribute to the development of neurodegenerative disorders (Wang et al., 2013a) .
Axonal transport of mitochondria along microtubules is mediated by motor proteins, kinesins, and dyneins. In axons, kinesins, linked to the outer mitochondrial membrane protein Miro, through the adaptor proteins Milton/Trak, mediate anterograde transport, whereas cytoplasmic dyneins mediate retrograde transport (MacAskill and Kittler, 2010) . Additionally, motor proteins' function is highly regulated by Ca 2+ (Macaskill et al., 2009; Wang and Schwarz, 2009 ) and critically dependent on ATP locally produced by mitochondria (Sheng and Cai, 2012) . In Drosophila neurons, a Miro-dependent regulation of retrograde axonal transport of mitochondria was also described (Russo et al., 2009) . Microtubule-associated protein Tau, by assembly and maintenance of microtubules, also plays a major role in neuronal mitochondrial trafficking control (Kopeikina et al., 2011; Llorens-Martín et al., 2011; Vossel et al., 2010) . Tau function is largely dependent on its phosphorylation status (Llorens-Martín et al., 2011; Shahpasand et al., 2012) . Notably, MDMA was reported to raise intracellular free Ca 2+ levels in cultured hippocampal neurons (Barbosa et al., 2014c) , and also to increase Tau's phosphorylation in both mouse hippocampus (Busceti et al., 2008) and cultured hippocampal neurons (Barbosa et al., 2014c) , thus suggesting a possible direct interference of MDMA on mitochondrial dynamics.
By controlling organelle size, mitochondrial fission/fusion events also regulate an efficient microtubule-mediated active transport in neurons (Itoh et al., 2013) . Accordingly, Mfn2 was recently described as necessary for neuronal mitochondrial transport, by interacting with the Miro/Milton complex (Misko et al., 2010) . Also, a Drp1-dependent regulation of mitochondrial density in dendrites (Li et al., 2004) and a prevention of axonal transport of mitochondria in the absence of fission events (Verstreken et al., 2005) were reported, illustrating the interplay between mitochondrial fission/fusion events and movement.
Considering that MDMA and its metabolites coexist in the brain, our hypothesis is that their mixture, at a range of concentrations relevant to the in vivo scenario, may dysregulate mitochondrial dynamics. To this end, by using real-time fluorescence video-microscopy at single-cell resolution, we evaluated the putative disrupting effects of the mixture of MDMA and its metabolites on mitochondrial fusion/fission and trafficking.
MATERIALS AND METHODS

Materials.
All reagents used were of analytical grade or of the highest grade available. Neurobasal medium, B27 supplement, penicillin/streptomycin 10,000 U/ml, GlutaMAX TM supplement, 0.5% trypsin/ethylenediaminetetraacetic acid (EDTA) without phenol red, heat inactivated horse serum, Opti-MEM medium, Lipofectamine 2000 and Dulbecco's phosphate buffered saline (DPBS) were purchased from Gibco Laboratories (Lenexa, KS). Poly-l-lysine (PLL), triton X-100, Na 3 VO 4 , NaF, Tris·HCl, bromophenol blue, ␤-mercaptoethanol and 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium (Capela et al., 2006 (Capela et al., , 2007 .
Animals. All procedures involving animals were approved by the Barcelona Scientific Park's Animal Experimentation Committee and were carried out in accordance with the "Guide for the Care and Use of Laboratory Animals" from the Institute for Laboratory Animal Research (Research, 2011) , and the European Community Council's directive and the National Institute of Health's guidelines for the care and use of laboratory animals. Animals were allowed free access to a standard chow diet and water and maintained on a 12 h/12 h light/dark cycle under specific pathogen free conditions in the Barcelona Scientific Park's Animal Research Center. To prepare primary hippocampal cultures, OF1 embryos from mice (Charles River, France) and C57BL/6 Tau (−/−) mice's embryos were used, at embryonic day 15 (E15) to E16, considering the mating day as E0. All procedures were taken to minimize the number of animals used and their suffering.
Cell culture and transfection. Primary neuronal cultures of hippocampus were prepared according to previously published methods (Barbosa et al., 2014c) . Pregnant mice were killed by cervical dislocation, and embryos were placed in ice-cold DPBS without Ca 2+ and Mg 2+ [DPBS (−/−)] containing 0.6% glucose during all dissection procedures. After brain isolation, meninges were removed, and hippocampus was dissected. Following a trypsinization (0.05% trypsin/EDTA) for 10 min, at 37
• C, a DNAse I treatment was applied, followed by another incubation period of 10 min, again at 37
• C. After dissociation of the tissue pieces by gently sweeping, cellular suspension was centrifuged at 127× g, for 5 min, at 4
• C, and resuspended in complete medium (neurobasal medium supplemented with 2% B27, 100 U/ml penicillin, 100 g/ml streptomycin, and 2mM Glutamax TM ). Cells were then seeded at a density of 78,000 cells/cm 2 . For live-imaging, hippocampal cultures were seeded in precoated 35 mm Fluordish plates (World Precision Instruments, Florida), whereas for western blotting analysis, precoated six-well plates (Nunc, Roskilde, Denmark), were used. To evaluate mitochondrial length, hippocampal cultures were seeded in 12 mm round precoated glass coverslips. Precoating was performed by overnight incubation, at 37
• C, with 0.2 mg/ml PLL solution (prepared in 0.1M borate buffer, pH 8.5). Cultures were maintained at 37
• C, in an atmosphere of 5% CO 2 /95% air and used for experiments at 5 days in vitro (DIV). Hippocampal cultures were transfected, at 4DIV, with DNAencoding plasmids MitDsRed (a gift from Antonio Zorzano) and green fluorescent protein (GFP), or cotransfected with another of the following constructs: Mfn2 (Misko et al., 2010) , Mfn2 R94Q (Misko et al., 2012) , or Drp1 K38A (Zhao et al., 2011) , using Lipofectamine 2000 as transfection reagent and following the manufacturer's instructions. In humans, as in rats, MDMA undergoes a nonlinear pharmacokinetics, in which its brain concentration increases nonlinearly with the dose (Baumann et al., 2009; Concheiro et al., 2014; De La Torre et al., 2000) . Furthermore, in the rat model, high doses of MDMA (up to 10 mg/kg) were described to saturate hepatic metabolism, via enzymatic inhibition, thus slowing the rate of N-demethylation (Baumann et al., 2009; Concheiro et al., 2014; De La Torre et al., 2000) . Additionally, in vitro studies suggest that MDMA can act as inhibitor of the cytochrome P450 (CYP) 2D6 isoenzyme, which is important for the N-Me-␣-MeDA formation. This effect is likely to result from a competitive interaction and/or formation of a metabolic intermediate complex between MDMA and this enzyme (Delaforge et al., 1999; Heydari et al., 2004) , though it lacks in vivo confirmation. Nevertheless, in a human controlled study, following a single 100 mg oral dose of MDMA, N-Me-␣-MeDA reached plasma concentrations similar to those observed for MDMA (154.5 g/l vs. 181.6 g/l, respectively; Segura et al., 2001 ), clearly demonstrating a high formation rate for this catecholic metabolite.
Following oral administration of MDMA (20 mg/kg) to rats, high concentrations of MDMA were found in the brain (17.17 nmol/g brain) (Mueller et al., 2009) . Similarly, after subcutaneous injection (from 5 to 20 mg/kg), brain concentrations of MDMA ranged from 0.74 to 147.65 nmol/g brain, and plasma concentrations reached 15.78M (Chu et al., 1996) , showing, therefore, that the brain accumulation of MDMA is clearly favored. Furthermore, it was also shown the presence of MDMA catecholic metabolites (Chu et al., 1996) and their correspondent GSH and NAC conjugates (Erives et al., 2008; Jones et al., 2005) in the brain following subcutaneous administration of MDMA (20-40 mg/kg) to rats, clearly demonstrating the compounds' ability to cross the blood-brain barrier. Interestingly, the combined concentration of the four thioether metabolites in the rat brain striatal dialysate reached the concentration of 13M, which remained relatively unchanged for approximately 4 h after exposure to MDMA (4 × 20 mg/kg subcutaneous, at 12-h interval; Erives et al., 2008) . Additionally, it is important to consider that NAC-conjugated metabolites of MDMA are formed in the brain (Esteban et al., 2001 ) and, therefore, the blood-brain barrier does not interfere with their brain bioavailability. This indicates that MDMA and metabolites may reach brain concentrations even higher than the ones used in our mixture composition. Thus, it is feasible to consider our mixture concentration and composition a relevant model to the in vivo scenario.
Live-imaging of axonal transport of mitochondria in hippocampal neurons.
Live-imaging of axonal transport of mitochondria in hippocampal neurons was performed using an Olympus IX81 confocal microscope (Olympus Corporation, Tokyo, Japan), equipped with a 60x immersion objective, and an Andor Revolution XD spinning disk confocal microscopy system composed of a iXonEM + EM-CCD camera (Andor Tecnology, Belfast, United Kingdom) and FRAPPA, and solidstate laser combiner (ALC-UVP 350i, Andor Tecnology) with the renowned CSU-X1 confocal scanner (Yokogawa Electric Corporation, Tokyo, Japan). All cultures were kept at 37
• C, using a heating insert on the microscope stage and an incubating chamber, allowing circulation of a control CO 2 (5%)-air heated mixture for pH control. For measurements of axonal transport of mitochondria, axonal processes in transfected hippocampal neurons were identified following morphological criteria, and directionally determined for each axon. Time-lapse series of image stacks composed of 151 images (512 × 512 pixels) were taken every 6 s, over the course of 15 min. All 151 images obtained were processed mainly with Andor IQ2 software (Andor Technology). Further images' processing and analysis and videos' compilation and edition was done with FIJI (Image JA v1.45b, Open source software, NIH). Kymographs were generated with MetaMorph Software (Molecular Devices -MDS Analytical Technologies, Sunnyvale, CA). In our presentation of kymographs, the vertical axis represents the time, and the horizontal axis is the distance along a slice. Stationary mitochondrial sites are identified as vertical lines on the kymographs. Motile mitochondria appear as diagonal lines, and their slopes provide the velocity. Distances and speeds of anterograde (from proximal to distal) and retrograde (from distal to proximal) motile mitochondria were measured separately from the corresponding kymographs. In all cases, a mitochondrion was considered motile when it moved more than 5 m during the 15 min of recording. Mitochondrion motile in both anterograde and retrograde directions was considered a single mitochondrion, although it was included in both anterograde and retrograde moving mitochondria groups. For qualitative imaging of axonal transport of mitochondria, MitDsRed and GFP were excited at 561 and 488 nm and fluorescence emission was collected at 592 and 508 nm, respectively.
Western blotting analysis of Tau protein. Cellular proteins
were extracted with lysis buffer [50mM Tris·HCl pH 7.5, 150mM NaCl, 5mM EDTA, 1% triton X-100 (vol/vol), 10% glycerol (vol/vol), complete protease's inhibitor cocktail, 1mM Na 3 VO 4 , 10mM Na 4 P 2 O 7 , and 10mM NaF], followed by an incubation on ice for 30 min. After centrifugation at 16,000 × g, for 10 min, at 4
• C, a SDS-PAGE reducing buffer [150mM Tris·HCl pH 6.8, 3% SDS (wt/vol), 30% glycerol (vol/vol), 0.075% bromophenol blue (wt/vol) and 15% ␤-mercaptoethanol (vol/vol)] was added to the samples (1:2 ratio), which were then boiled at 90
• C for 5 min. Proteins were loaded and separated in 10% SDS/polyacrylamide gels, at a constant voltage of 120 mV. Gels were transferred to nitrocellulose membranes (Whatman, Dassel, Germany) using a transfer buffer (20% methanol (vol/vol) in 20mM Tris base and 139mM glycine), at 125 mV, for 1.5 h. Membranes were then rinsed in Tris-buffered saline solution with Tween 20 [TBS-T: 10mM Tris base, 140mM NaCl and 0.1% Tween 20 (vol/vol), pH 7.4], and nonspecific sites were blocked for 1 h, at room temperature, in blocking buffer [3% bovine serum albumine (BSA) (wt/vol) in TBS-T]. Membranes were incubated with primary antibodies (overnight at 4
• C): mouse monoclonal antiTau1 (1:50,000) or anti-␣-actin (1:100,000). After washing five times (10 min each) with TBS-T membranes were then incubated with the antimouse IgG-peroxidase secondary antibody (1:2500), for 1 h, at room temperature. All antibodies were diluted in blocking buffer. Following three washes (10 min each) with TBS-T, bands were visualized using ECL chemiluminescence reagents (Amersham Pharmacia Biotech, Buckinghamshire, United Kingdom), according to the supplier`s instructions, and quantified using the Quantity One software (Bio-Rad Laboratories).
Mitochondrial length measurements. Hippocampal cultures seeded in 12 mm round precoated glass coverslips, and transfected with MitDsRed and GFP, were incubated with the mixture of MDMA and its metabolites for 24 h and then fixed in 4% paraformaldehyde, for 20 min, at room temperature. Images were acquired in a Leica TCS SP2 confocal microscope (Leica Microsystems, Mannheim, Germany), equipped with a 60x immersion objective. Stacks of images (1024 × 1024 pixels) were acquired with Leica Confocal Software (Leica Microsystems). Further image processing and analysis was done with Fiji (NIH). Mitochondria in axonal processes were visualized by mitochondrial targeted MitDsRed. Mitochondrial length was estimated individually for each mitochondrion. To identify axonal processes GFP was excited at 488 nm, and fluorescence emission was collected at 508 nm. MitDsRed was excited at 561 nm and fluorescence intensities were collected at 592 nm. Data analysis. Values in figures and text are presented as mean ± SEM of the indicated number of independent experiments. Each independent experiment was performed with hippocampal cultures originating from different pregnant mice. Normality of the data distribution was assessed by three tests (Kolmogorov-Smirnov, D'Agostino and Pearson omnibus and Shapiro-Wilk normality tests). In experiments with only one variable, statistical comparisons between groups were performed with one-way ANOVA, followed by Bonferroni's test for post-hoc evaluations, or with Mann-Whitney's test. Twoway ANOVA followed by Bonferroni's post hoc test was used to analyze the data from experiments with two variables. Details of the performed statistical analysis are described in each figure legend. Differences were considered to be significant at p values lower than 0.05. All analyses were performed using GraphPad Prism 6.0 for Windows (GraphPad Software, San Diego, CA).
RESULTS
The Mixture of MDMA and its Metabolites, at In Vivo Relevant Concentrations, Impaired Axonal Transport of Mitochondria in Hippocampal Neurons
Based on a recent study published by our laboratory, in which it was demonstrated, for the first time, that the mixture of MDMA and its metabolites, at in vivo relevant concentrations, elicited cellular adaptations and toxicity in human SH-SY5Y differentiated cells (Barbosa et al., 2014b) , two different compositions of the mixture of MDMA and its metabolites, each compound at 10M or each compound at 20M, were tested. Twenty four hours of exposure to the mixture of MDMA and its metabolites ␣-MeDA, N-Me-␣-MeDA, 5-(GSH)-␣-MeDA, 5-(GSH)-N-Me-␣-MeDA, 5-(NAC)-␣-MeDA, and 5-(NAC)-NMe-␣-MeDA, each compound at 20M, resulted in significant toxicity to the culture, as evaluated by the MTT reduction assay (Fig. 1) . Nevertheless, exposure to the 10M mixture, for 24 h, did not cause significant toxicity to hippocampal cultures (Fig.  1) . Therefore, the 10M mixture was selected for our further functional studies.
In humans, MDMA-induced neuronal deficits have been reported in discrete areas of the brain, such as cortex, striatum, raphe nuclei, and hippocampus (Capela et al., 2009; Carvalho et al., 2012; Parrott, 2012) . Mitochondrial trafficking is a key regulator process in maintaining neuronal function and survival, because mitochondria need to be distributed from cell body, where they are synthesized, to axons and dendrites, to facilitate adequate energy supply and Ca 2+ buffering (Sheng and Cai, 2012) . Therefore, by using cultured hippocampal neurons, we aimed to evaluate the putative effects of the mixture of MDMA and its metabolites, which represent a more real scenario of in vivo exposure to MDMA, on axonal transport of mitochondria. Control neurons exhibited prominent mitochondrial trafficking, with an average of 65% of motile mitochondria, moving in both anterograde and retrograde directions, at Fig. 2 and Supplementary movie  2) . Analysis of the data showed a significant reduction on mitochondrial motility (control = 65.27 ± 4.89%; mixture = 42.56 ± 5.90%, p < 0.05), which was revealed in both anterograde (control = 43.37 ± 3.57%; mixture = 30.51 ± 4.62%, p < 0.05) and retrograde (control = 40.01 ± 4.61%; mixture = 24.84 ± 4.72%, p < 0.05) directions. Though anterograde velocity was not significantly changed (control = 0.394 ± 0.024 m/s; mixture = 0.330 ± 0.042 m/s), an impairment in retrograde velocity was observed (control = 0.474 ± 0.033 m/s; mixture = 0.264 ± 0.041 m/s, p < 0.01). Thus, these results indicate that the mixture of MDMA and its metabolites, at a range of concentrations with relevance to the in vivo scenario (Chu et al., 1996; Erives et al., 2008; Jones et al., 2005) , impaired axonal transport of mitochondria.
Tau Protein did not Play a Major Role on the Mitochondrial Trafficking Deficits Triggered by the Mixture of MDMA and its Metabolites
Previous studies have attributed an important role for Tau protein in regulating axonal transport of mitochondria (Kopeikina et al., 2011; Llorens-Martín et al., 2011; Shahpasand et al., 2012; Vossel et al., 2010) , though anterograde and retrograde movements appear to be differently modulated (Dixit et al., 2008) . Furthermore, Tau protein function in regulating mitochondrial trafficking is critically dependent on its phosphorylation ratio (Llorens-Martín et al., 2011; Shahpasand et al., 2012) . By using Tau (−/−) neurons (Fig. 3A) we studied the involvement of Tau protein on mitochondrial trafficking impairment associated with the mixture of MDMA and its metabolites. As shown in Figure 3 , the lack of Tau protein significantly restored the deficits triggered by the mixture of MDMA and its metabolites in retrograde mitochondrial velocity. However, none of the remaining transport parameters evaluated were significantly modified, thus indicating a minor role for Tau protein on the reported trafficking phenotype.
Increased Fragmentation of Axonal Mitochondria was Linked to the Trafficking Deficits Triggered by the Mixture of MDMA and its Metabolites
Neurons are critically dependent on mitochondrial dynamics to ensure correct ATP supply and Ca 2+ homeostasis (Sheng and Cai, 2012) . Though a direct involvement of the profusion protein Mfn2 in regulating mitochondrial neuronal trafficking has been described (Misko et al., 2010 (Misko et al., , 2012 , the role of fission events on mitochondrial trafficking control has not been completely elucidated. However, despite this emerging relationship (Li et al., 2004; Verstreken et al., 2005) , little is known regarding the response of mitochondrial fission/fusion to disease and stress. To confirm whether the mitochondrial trafficking deficits observed were associated with deregulation in mitochondrial fusion/fission events, we evaluated mitochondrial length on axonal extensions. Control mitochondria exhibited an average length of 0.555 ± 0.021 m, whereas axonal mitochondria from neurons exposed to the mixture of MDMA and its metabolites were significantly shorter, with an average length of 0.429 ± 0.011 m (p < 0.0001, Fig. 4A) . Therefore, the impairment of mitochondrial movement induced by the mixture of MDMA and its metabolites was associated with increased fragmentation of axonal mitochondria.
Overexpression of Mitofusin2 or Drp1 K38A almost Completely Rescued the Mitochondrial Trafficking Deficits Triggered by the Mixture of MDMA and its Metabolites
Though a relationship between fusion proteins, namely Mfn2, and mitochondrial transport was recently described (Detmer and Chan, 2007; Misko et al., 2010 Misko et al., , 2012 , whether the effect of Mfn2 on mitochondrial transport is related to its fusion properties is not completely established. Furthermore, the previous involvement of Drp1 in regulating mitochondrial density in dendrites (Li et al., 2004) and axonal transport of mitochondria (Verstreken et al., 2005) suggests that a deregulation of mitochondrial fusion/fission equilibrium, as observed by increased fragmentation of axonal mitochondria (Fig. 4A) , may be related to the reported mitochondrial trafficking phenotype. As shown in Figures 4B-4D , overexpression of wild-type Mfn2 completely rescued the mitochondrial transport deficits elicited by the mixture of MDMA and its metabolites, when compared with Mfn2-nontransfected neurons. Similarly, overexpression of Drp1 K38A, a dominant negative construct that lacks fission properties (Zhao et al., 2011) , almost completely rescued the mixture-induced mitochondrial trafficking impairment, as compared with respective Drp1 K38A-nontransfected counterparts (Fig. 5) . Thus, these findings indicate that proteins/mechanisms involved in mitochondrial fission/fusion may be disrupted by exposure to the mixture of MDMA and its metabolites, causing mitochondrial trafficking arrest in cultured hippocampal neurons.
CMT2A-Associated Mitofusin2 Mutant did not Rescue the Mitochondrial Trafficking Phenotype Induced by the Mixture of MDMA and its Metabolites
Charcot-Marie-Tooth's 2A disease, an autosomal dominant sensory-motor neuropathy, is associated with several mutations in Mfn2. One of these mutant forms is Mfn2 R94Q, which is characterized by impaired mitochondrial fusion properties (Detmer and Chan, 2007) . Furthermore, this mutant protein is reported to produce a marked decrease in overall mitochondrial motility in axons of cultured sensory neurons (Baloh et al., 2007) and altered mitochondrial distribution and transport along axons of dorsal root ganglion neurons (Misko et al., 2010 (Misko et al., , 2012 . Therefore, we transfected hippocampal neurons with Mfn2 R94Q to appraise the relative contribution of fission/fusion-dependent mechanisms in regulating the mitochondrial trafficking phenotype triggered by the mixture of MDMA and its metabolites. As shown in Figure 6 , overexpression of Mfn2 R94Q did not modify the mixture-induced mitochondrial trafficking impairment, when compared with Mfn2 R94Q-nontransfected neurons. Thus, consistent with our experiments performed with wild-type Mfn2 and Drp1 K38A overexpressing neurons, these results indicate a critical dependence on mitochondrial fission/fusion-dependent mechanisms for the mitochondrial trafficking arrest caused by the mixture of MDMA and its metabolites. In (D), the graphical representation of the percentage of total motile mitochondria, motile mitochondria in anterograde or retrograde directions, and velocity in both anterograde and retrograde directions, as in kymographs, are showed. Data were analyzed using two-way ANOVA, followed by Bonferroni's test for post-hoc evaluations, and represent the mean ± SEM of 10-19 axons (neurons) per experimental group, from at least three independent experiments [*p < 0.05, **p < 0.01, ***p < 0.001 mixture vs. control; # p < 0.05, ## p < 0.01 Tau (−/−) vs. wild-type; ns: not significant]. Scale bar: 10 m.
DISCUSSION
The present study clearly shows, for the first time, that the mixture of MDMA and its metabolites, at in vivo relevant concentrations, impaired axonal transport of mitochondria and increased mitochondrial fragmentation in cultured hippocampal neurons. Furthermore, by overexpressing wild-type or mutant proteins, mitochondrial fission/fusion-dependent mechanisms were implicated in the reported trafficking phenotype. Lastly, by using Tau (−/−) neurons, a minor role for Tau protein on the mixture-triggered mitochondrial trafficking impairment was revealed.
High energy demands and the requirement to maintain cellular homeostasis at sites distant to the cell body make neurons particularly vulnerable to mitochondrial dysfunction (Itoh et al., 2013) . Indeed, where extended arborization requires longdistance maneuvering of intracellular components, it has been suggested that disrupted mitochondrial translocation may contribute to the pathophysiology of neuronal injury (Deheshi et al., 2013) . Furthermore, there is emerging evidence suggesting that the damage of terminal axons may occur independently and by distinct mechanisms from those of cell bodies (Lee et al., 2012) . Importantly, selective damage to terminal axons is a characteristic marker of MDMA-associated neurotoxicity (Capela et al., 2009) .
In recent years, a more detailed picture has emerged about the cellular mechanisms ensuring mitochondrial integrity, and their relevance for neuronal degeneration. In the field of MDMA research, there is a general consensus that disruption of mitochondrial function likely contributes to pathological processes underlying MDMA's neurotoxicity (Alves et al., 2007 (Alves et al., , 2009a Puerta et al., 2010; Quinton and Yamamoto, 2006) . In fact, inhibition of mitochondrial respiratory complexes' proteins (Puerta et al., 2010; Quinton and Yamamoto, 2006) , oxidation of mitochondrial macromolecules (Alves et al., 2007 (Alves et al., , 2009a and deletions of mitochondrial DNA (Alves et al., 2007 (Alves et al., , 2009a have been associated with MDMA-induced neurotoxicity. Therefore, it is expected that mitochondrial dysfunction may be crucial in MDMA's neurotoxic effects.
Human studies have indicated that the memory and learning dysfunction in heavy MDMA users may be related to the drug's actions on hippocampus (Gouzoulis-Mayfrank et al., 2003) . Furthermore, animal studies have demonstrated the vulnerability of this brain area to MDMA's effects, including longlasting memory deficits and deletions of mitochondrial DNA (Alves et al., 2007 (Alves et al., , 2009a Capela et al., 2009) . Altogether, these findings indicate a particular susceptibility of this brain area to MDMA's actions, thus rendering hippocampal cultures a relevant model to study MDMA-induced toxic effects at the mitochondrial level.
In accordance with previous studies, which have shown that MDMA and several of its metabolites coexist in the brain following peripheral administration of the drug (Chu et al., 1996; Erives et al., 2008; Jones et al., 2005) This study demonstrates, for the first time, that this mixture, at in vivo relevant concentrations, dramatically impaired mitochondrial trafficking along axons of cultured hippocampal neurons, as revealed by the reduced mitochondrial movement in anterograde and retrograde directions, as well as by a significant reduction in retrograde velocity. Considering the critical dependence of neurons on mitochondrial transport regarding proper energy supply and synaptic function (MacAskill and Kittler, 2010; Sheng and Cai, 2012) , these results provide a new, and important, insight in the context of "ecstasy"-induced deleterious effects to the central nervous system. Additionally, these data suggest that alterations in neuronal mitochondrial trafficking may contribute to the acute-and long-lasting effects of MDMA in the brain.
A number of studies have suggested that increased expression or altered microtubule-binding of Tau may compromise axonal transport of mitochondria (Kopeikina et al., 2011) . However, other studies have described a Tau-independent regulation of axonal transport (Yuan et al., 2008) . Here, we showed that the trafficking impairment induced by the mixture of MDMA and its metabolites in Tau (−/−) neurons was comparable to the one found in wild-type neurons (only a partial rescue in retrograde velocity was found). In a previous study, we showed a partial dependence on Tau protein in MDMA-induced mitochondrial trafficking impairment, by exposing cultured hippocampal neurons to a high concentration of MDMA (Barbosa et al., 2014c) . In this study, the minor dependence on Tau protein for the reported effect suggests that Tau-independent mechanisms are responsible for the mitochondrial trafficking arrest caused by a low concentration mixture of MDMA and its metabolites.
Fission events fragment mitochondria into smaller units, thus allowing mitochondrial transport to different subcellular localizations, such as nerve terminals (Itoh et al., 2013) . In this study, hippocampal neurons exposed to the mixture of MDMA and its metabolites presented mitochondria of reduced size, indicating increased mitochondrial fragmentation. Noteworthy, changes in mitochondrial morphology, resulting from excessive fission, have been associated with numerous neurodegenerative disorders (Rintoul and Reynolds, 2010; Wang et al., 2013a) and neuronal injury (Frank et al., 2001; Wang et al., 2013a) . Furthermore, oxidative stress, a common outcome in MDMA-related neuronal injury (Barbosa et al., 2012 (Barbosa et al., , 2014a Capela et al., 2007 Capela et al., , 2009 ), appears to modify mitochondrial response to fission events, resulting in increased mitochondrial fragmentation (Ghose et al., 2013; Wang et al., 2013b) . In accordance, in a neuronal model of Parkinson's disease, the neuronal injury observed under oxidative stress conditions was prevented by chemical inhibition of mitochondrial fission (Qi et al., 2012) . Therefore, the increased mitochondrial fragmentation observed in this study suggests that the mixture of MDMA and its metabolites may alter mitochondrial fusion/fission equilibrium, a mitochondrial processing event, and, thus, contribute to the MDMA-induced neuronal dysfunction. However, though it is clear that mitochondrial fission plays a major role in restoring dysfunctional mitochondria and regulating mitochondrial transport (Verstreken et al., 2005) , whether mitochondrial dysfunction is the cause or a consequence of impaired mitochondrial transport remains unknown.
Like fission, mitochondrial fusion is also required for proper mitochondrial distribution in neurons (Baloh et al., 2007; Misko et al., 2010 Misko et al., , 2012 ). Mfn2 appears to be critical in maintaining neuronal function and integrity, because its loss-of-function causes abnormal mitochondrial morphology, respiratory chain dysfunction and severe reduction of dopaminergic terminals in Data were analyzed using two-way ANOVA, followed by Bonferroni's test for post-hoc evaluations, and represent the mean ± SEM of 18-19 different axons (neurons) per experimental group, from four independent experiments (*p < 0.05, **p < 0.01, ****p < 0.0001 mixture vs. control; ns: not significant). Scale bar: 10 m. mouse striatum (Lee et al., 2012) . In neurons, as in other cell types, the mutant fission protein Drp1 K38A, acting as a dominant negative, inhibits endogenous fission without affecting the normal activity of fusion proteins (Zhao et al., 2011) . In this study, it was demonstrated that the overexpression of Mfn2 or Drp1 K38A almost completely rescued the mixture-induced mitochondrial trafficking deficits, as compared with the respective Mfn2-or Drp1 K38A-nontransfected counterparts. However, Mfn2 overexpression was more effective than Drp1 K38A in preventing mitochondrial trafficking impairment. Additionally, in hippocampal neurons overexpressing the dominant negative Mfn2 mutant R94Q, a CMT2A mutant construct with impaired fusion (Detmer and Chan, 2007) and transport properties (Misko et al., 2010 (Misko et al., , 2012 , the mitochondrial trafficking impairment caused by the mixture of MDMA and its metabolites was not significantly changed, when compared with Mfn2 R94Q-nontransfected neurons. In control neurons, overexpression of Mfn2 or Mfn2 R94Q (with GFP and MitDsRed), did not significantly change any of the parameters assessed, compared with their nontransfected counterparts (only transfected with GFP and MitDsRed). Drp1 K38A overexpressing neurons (with GFP and MitDsRed) showed, however, higher anterograde velocity when compared with their respective nontransfected controls (only transfected with GFP and MitDsRed). These data indicate that fully functional Mfn2 was required to reverse the mixture-induced impaired mitochondrial trafficking. Additionally, because Mfn2 and Drp1 largely mitigated the mitochondrial trafficking deficits induced by the mixture of MDMA and its metabolites, these experiments also suggest that this mixture may alter the mitochondrial fusion/fission equilibrium, consistent with the reported increase in the fragmentation of axonal mitochondria.
The loss of synaptic terminals in MDMA-administrated rats is by far the most reported neurotoxic event associated with this drug of abuse (Capela et al., 2009; Rudnick and Wall, 1992) . Therefore, as neuronal mitochondrial trafficking and targeting to neuronal compartments and synapses are critical for many neuronal functions, including energy production and correct synaptic transmission (Barbosa et al., 2014c; López-Doménech et al., 2012; Sheng and Cai, 2012) , we postulate 418 BARBOSA ET AL. that disrupted mitochondrial trafficking may contribute to the MDMA's neurotoxic and/or psychostimulant effects. Additionally, because alterations in mitochondrial morphology resulting from a failure of mitochondrial quality control mechanisms, like fusion/fission events, may ultimately result in a collapse of mitochondrial network and neuronal injury (Rugarli and Langer, 2012) , these data describe a potential new mechanism underlying the effects of MDMA and its metabolites at the neuronal level. Lastly, with the experimental approach introduced in this study, in which low micromolar concentrations of MDMA and its main in vivo metabolites were combined in a mixture, thus becoming more representative of the in vivo scenario, these data provide a new breakthrough in the field of MDMA research, which may help in clarifying the mechanisms involved in MDMA-induced neuronal dysfunction, degeneration, and neurotoxicity.
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